Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy

BJU International
Nilay PatelMark Sullivan

Abstract

Study Type - Therapy (case series) Level of Evidence 4. What's known on the subject? and What does the study add? Active surveillance of small renal masses has traditionally been reserved for elderly patients deemed unfit for surgery or ablation. There is increasing evidence showing the safety of active surveillance in the management of small renal masses. In this retrospective study we compared outcomes for patients with small renal masses managed with active surveillance, radical nephrectomy and partial nephrectomy. We showed that active surveillance was safe and appeared as effective as immediate surgery in the management of small renal tumours. • To compare the oncological outcomes of active surveillance (AS), radical nephrectomy (RN) and partial nephrectomy (PN) in the management of T1a small renal masses (SRMs). • At present AS is used in the treatment of SRMs in elderly patients with multiple co-morbidities or in those who decline surgery. • We identified all patients with T1a SRMs managed with RN, PN or AS. • Retrospective data were collected from patient case records with survival data and cause of death cross-referenced with the Oxford Cancer Intelligence Unit. • A total of 202 patients with 234 T1a SRMs (solid or Bos...Continue Reading

Associated Clinical Trials

References

May 2, 2002·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·A MathewW-H Chow
Sep 21, 2006·Journal of the National Cancer Institute·John M HollingsworthBrent K Hollenbeck
Feb 14, 2007·The Journal of Urology·David A KunkleRobert G Uzzo
Feb 19, 2008·The Journal of Urology·David A KunkleRobert G Uzzo
May 21, 2008·Cancer·Christopher J KanePeter R Carroll
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Aug 18, 2009·The Journal of Urology·Steven C CampbellUNKNOWN Practice Guidelines Committee of the American Urological Association
Nov 26, 2009·BJU International·Philip J S CharlesworthAndrew Protheroe
Feb 2, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayE Steliarova-Foucher
Mar 20, 2010·The Journal of Urology·Juan Carlos RosalesJaime Landman
Jul 17, 2010·European Urology·Börje LjungbergUNKNOWN European Association of Urology Guideline Group
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Apr 12, 2011·European Urology·Michael A S JewettAntonio Finelli
Apr 19, 2011·European Urology·David R Yates, Morgan Rouprêt
Jun 18, 2011·The Journal of Urology·Matthew R CooperbergPeter R Carroll
Sep 8, 2011·BJU International·Véronique PhéMorgan Rouprêt

❮ Previous
Next ❯

Citations

Mar 27, 2013·International Urology and Nephrology·Benjamin WoodsonBenjamin R Lee
Sep 11, 2012·European Urology·Sarah P PsutkaDebra A Gervais
Nov 28, 2012·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·L FrogerT Lebret
May 30, 2013·BJU International·Andreas BeckerMaxine Sun
Nov 7, 2015·SpringerPlus·Ofer N GofritDov Pode
Sep 1, 2015·Radiologic Clinics of North America·Gregory T FreyThomas D Atwell
Nov 7, 2014·World Journal of Urology·J C BernhardUNKNOWN NEPHRON Study Group
Apr 25, 2016·Abdominal Radiology·Lakshmi AnanthakrishnanJohn R Leyendecker
Jun 21, 2016·International Journal of Surgery·Alessandro Volpe
Nov 3, 2016·World Journal of Urology·Kenan E CeltikLouis R Kavoussi
Jan 18, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio FinelliPaul Russo
Oct 2, 2015·Therapeutic Advances in Urology·Michael L BluteEdwin Jason Abel
May 10, 2017·The Cochrane Database of Systematic Reviews·Frank KunathNils Kroeger
Aug 13, 2014·Nature Reviews. Urology·Jaimin R Bhatt, Antonio Finelli
Jun 20, 2013·Current Opinion in Urology·Martin KathrinsThomas Guzzo
Jun 23, 2016·Journal of Computer Assisted Tomography·Megha NayyarVinay Duddalwar
Jun 20, 2020·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Giovanni MauriFranco Orsi
Oct 16, 2019·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·K BensalahA Méjean

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.